Correlation Between VentriPoint Diagnostics and JPMorgan Chase

Can any of the company-specific risk be diversified away by investing in both VentriPoint Diagnostics and JPMorgan Chase at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VentriPoint Diagnostics and JPMorgan Chase into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between VentriPoint Diagnostics and JPMorgan Chase Co, you can compare the effects of market volatilities on VentriPoint Diagnostics and JPMorgan Chase and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VentriPoint Diagnostics with a short position of JPMorgan Chase. Check out your portfolio center. Please also check ongoing floating volatility patterns of VentriPoint Diagnostics and JPMorgan Chase.

Diversification Opportunities for VentriPoint Diagnostics and JPMorgan Chase

-0.83

Correlation Coefficient

VentriPoint Diagnostics  JPMorgan Chase

Pay attention - limited upside

The 3 months correlation between VentriPoint and JPMorgan is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding VentriPoint Diagnostics and JPMorgan Chase Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on JPMorgan Chase and VentriPoint Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VentriPoint Diagnostics are associated (or correlated) with JPMorgan Chase. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of JPMorgan Chase has no effect on the direction of VentriPoint Diagnostics i.e., VentriPoint Diagnostics and JPMorgan Chase go up and down completely randomly.

Pair Corralation between VentriPoint Diagnostics and JPMorgan Chase

Assuming the 90 days horizon VentriPoint Diagnostics is expected to under-perform the JPMorgan Chase. In addition to that, VentriPoint Diagnostics is 4.13 times more volatile than JPMorgan Chase Co. It trades about -0.01 of its total potential returns per unit of risk. JPMorgan Chase Co is currently generating about 0.09 per unit of volatility. If you would invest  1,728  in JPMorgan Chase Co on September 19, 2024 and sell it today you would earn a total of  1,445  from holding JPMorgan Chase Co or generate 83.62% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

VentriPoint Diagnostics  vs.  JPMorgan Chase Co

VentriPoint Diagnostics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days VentriPoint Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

JPMorgan Chase

Risk-Adjusted Performance

6 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in JPMorgan Chase Co are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, JPMorgan Chase may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with VentriPoint Diagnostics and JPMorgan Chase

The main advantage of trading using opposite VentriPoint Diagnostics and JPMorgan Chase positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VentriPoint Diagnostics position performs unexpectedly, JPMorgan Chase can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in JPMorgan Chase will offset losses from the drop in JPMorgan Chase's long position.

The idea behind VentriPoint Diagnostics and JPMorgan Chase Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.